BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2209634)

  • 1. Clinical experience in gynecological cancer management. b) Vulvar cancer: report from the Gynecologic Institutes of Padua University (1963-1989).
    Onnis A; Marchetti M; Maggino T; De Toffoli J
    Eur J Gynaecol Oncol; 1990; 11(3):161-9. PubMed ID: 2209634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience in gynecological cancer management. c). Cervical cancer: report from the Gynecologic Institutes of Padua University (1963-1989).
    Onnis A; Marchetti M; Maggino T; De Toffoli J; Piazza M
    Eur J Gynaecol Oncol; 1991; 12(1):11-26. PubMed ID: 2050155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience in gynecological cancer management. Endometrial cancer: report from the gynecological institutes of Padua university (1963-1989).
    Onnis A; Marchetti M; Maggino T; Di Pasquale C; De Toffoli J
    Eur J Gynaecol Oncol; 1990; 11(1):1-11. PubMed ID: 2347329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
    Yuan GW; Li XG; Li N; Yao HW; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
    [No Abstract]   [Full Text] [Related]  

  • 7. Midline involvement as a risk factor for vulvar cancer recurrence.
    Stankevica J; Macuks R; Baidekalna I; Donina S
    Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the vulva: critical analysis of survival and treatment of recurrences.
    Onnis A; Marchetti M; Maggino T
    Clin Exp Obstet Gynecol; 1992; 19(2):87-92. PubMed ID: 1446398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991.
    Scheistrøen M; Nesland JM; Tropé C
    Eur J Gynaecol Oncol; 2002; 23(2):93-103. PubMed ID: 12013120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Forms of treatment and results in invasive vulvar cancer].
    Lahousen M
    Arch Gynecol Obstet; 1989; 245(1-4):517-23. PubMed ID: 2802738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.
    Zhou J; Shan G
    Curr Med Res Opin; 2016 Jun; 32(6):1121-30. PubMed ID: 26959073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.
    Farias-Eisner R; Cirisano FD; Grouse D; Leuchter RS; Karlan BY; Lagasse LD; Berek JS
    Gynecol Oncol; 1994 Apr; 53(1):55-8. PubMed ID: 8175023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-team simultaneous total radical vulvectomy and inguino-femoral lymphadenectomy via separate incisions for locally advanced (FIGO stages IB ≥ 4 cm-III) squamous vulvar cancer.
    Fambrini M; Sorbi F; Sisti G; Checcucci V; Cariti G; Scotti V; Tinacci E; Turrini I; Micaglio M; De Magnis A
    Anticancer Res; 2014 Dec; 34(12):7345-50. PubMed ID: 25503170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block.
    Dusenbery KE; Carlson JW; LaPorte RM; Unger JA; Goswitz JJ; Roback DM; Fowler JM; Adcock LL; Carson LF; Potish RA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):989-98. PubMed ID: 8083101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive squamous cell carcinoma of the vulva: behaviour and results in the light of changing management regimens. A review of clinicohistological features predictive of regional lymph node involvement and local recurrence.
    Lingard D; Free K; Wright RG; Battistutta D
    Aust N Z J Obstet Gynaecol; 1992 May; 32(2):137-45. PubMed ID: 1520199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage I squamous cell carcinoma of the vulva.
    Simonsen E; Johnsson JE; Tropé C; Alm P; Ranstam J
    Acta Radiol Oncol; 1984; 23(6):443-8. PubMed ID: 6099037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation?
    Manavi M; Berger A; Kucera E; Vavra N; Kucera H
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):749-53. PubMed ID: 9240642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sentinel node detection in vulvar cancer.
    Wydra D; Sawicki S; Emerich J; Romanowicz G
    Nucl Med Rev Cent East Eur; 2005; 8(2):128-30. PubMed ID: 16437399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.